These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 33509076)

  • 1. The prognostic value of MELD-XI in elderly patients with ST-segment elevation myocardial infarction: an observational study.
    He SJ; Weng JX; Chen HJ; Li HQ; Guo WQ; Cao Q; Xu S; Yan HB; Peng CN
    BMC Cardiovasc Disord; 2021 Jan; 21(1):53. PubMed ID: 33509076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MELD-XI score predict no-reflow phenomenon and short-term mortality in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Zhang XT; Lin ZR; Zhang L; Zhao ZW; Chen LL
    BMC Cardiovasc Disord; 2022 Mar; 22(1):113. PubMed ID: 35300593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the TIMI risk score in predicting mortality after primary percutaneous coronary intervention in elderly women: Results from a developing country.
    Furnaz S; Karim M; Ashraf T; Ali S; Shahid I; Ali S; Khawaja UA; Haque MTU; Usman MS; Siddiqi TJ
    PLoS One; 2019; 14(7):e0220289. PubMed ID: 31344139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: Results from the FAST-MI 2010 registry.
    Bailleul C; Aissaoui N; Cayla G; Dillinger JG; Jouve B; Schiele F; Ferrières J; Simon T; Danchin N; Puymirat E;
    Arch Cardiovasc Dis; 2018 Feb; 111(2):101-108. PubMed ID: 28939193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of SYNTAX score II efficacy with SYNTAX score and TIMI risk score for predicting in-hospital and long-term mortality in patients with ST segment elevation myocardial infarction.
    Karabağ Y; Çağdaş M; Rencuzogullari I; Karakoyun S; Artaç İ; İliş D; Yesin M; Öterkus M; Gokdeniz T; Burak C; Tanboğa IH
    Int J Cardiovasc Imaging; 2018 Aug; 34(8):1165-1175. PubMed ID: 29541904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age shock index and age-modified shock index are strong predictors of outcomes in ST-segment elevation myocardial infarction patients undergoing emergency percutaneous coronary intervention.
    Zhou J; Shan PR; Xie QL; Zhou XD; Cai MX; Xu TC; Huang WJ
    Coron Artery Dis; 2019 Sep; 30(6):398-405. PubMed ID: 31206405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the predictive value of the modified CADILLAC, GRACE and TIMI risk scores for the risk of short-term death in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention].
    Ji C; Song F; Huang X; Qu X; Qiu N; Zhu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Mar; 35(3):299-304. PubMed ID: 36916344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive prognostic value of left ventricular ejection fraction to the TIMI risk score for in-hospital and long-term mortality in patients with ST segment elevation myocardial infarction.
    Wei XB; Liu YH; He PC; Jiang L; Zhou YL; Chen JY; Tan N; Yu DQ
    J Thromb Thrombolysis; 2017 Jan; 43(1):1-6. PubMed ID: 27501999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of routine blood biomarkers to TIMI risk score improves predictive performance of 1-year mortality in patients with ST-segment elevation myocardial infarction.
    Oh PC; Eom YS; Moon J; Jang HJ; Kim TH; Suh J; Kong MG; Park SD; Kwon SW; Suh SY; Lee K; Han SH; Ahn T; Kang WC
    BMC Cardiovasc Disord; 2020 Nov; 20(1):486. PubMed ID: 33208092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and validation of a risk model for prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary PCI.
    Gao N; Qi X; Dang Y; Li Y; Wang G; Liu X; Zhu N; Fu J
    BMC Cardiovasc Disord; 2020 Dec; 20(1):513. PubMed ID: 33297955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twelve-month clinical outcomes of acute non-ST versus ST-segment elevation myocardial infarction patients with reduced preprocedural thrombolysis in myocardial infarction flow undergoing percutaneous coronary intervention.
    Baek JY; Kang TS; Rha SW; Choi BG; Park SH; Jeong MH
    Coron Artery Dis; 2018 Aug; 29(5):416-422. PubMed ID: 29708887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of mortality in patients with non-anterior ST-segment elevation myocardial infarction: Analysis from the HORIZONS-AMI trial.
    Huang X; Redfors B; Chen S; Gersh BJ; Mehran R; Zhang Y; McAndrew T; Ben-Yehuda O; Mintz GS; Stone GW
    Catheter Cardiovasc Interv; 2019 Aug; 94(2):172-180. PubMed ID: 30690854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive value of the MELD-XI score for short- and long-term mortality in elderly patients with non-ST elevation myocardial infarction.
    Çınar T; Şaylık F; Selçuk M; Akbulut T; Orhan AL
    Aging Clin Exp Res; 2022 Apr; 34(4):887-895. PubMed ID: 34648172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The investigation of TIMI risk index for prediction of contrast-induced acute kidney injury in patients with ST elevation myocardial infarction.
    Çınar T; Karabağ Y; Ozan Tanık V; Çağdaş M; Rencüzoğulları İ; Öz A
    Acta Cardiol; 2020 Feb; 75(1):77-84. PubMed ID: 30678606
    [No Abstract]   [Full Text] [Related]  

  • 15. Prediabetes versus type 2 diabetes mellitus based on pre-percutaneous coronary intervention thrombolysis in myocardial infarction flow grade in patients with ST-segment elevation myocardial infarction after successful newer-generation drug-eluting stent implantation.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Diab Vasc Dis Res; 2021; 18(1):1479164121991505. PubMed ID: 33535819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MELD-XI Score and Coronary Artery Disease Prevalence and Extent Among In-Hospital Patients With End-Stage Liver Failure Awaiting Transplant.
    Keskin S; Çiftci O; Moray G; Müderrisoğlu H; Haberal M
    Exp Clin Transplant; 2020 Jan; 18(Suppl 1):88-92. PubMed ID: 32008505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model for End-stage Liver Disease excluding INR (MELD-XI) score in critically ill patients: Easily available and of prognostic relevance.
    Wernly B; Lichtenauer M; Franz M; Kabisch B; Muessig J; Masyuk M; Hoppe UC; Kelm M; Jung C
    PLoS One; 2017; 12(2):e0170987. PubMed ID: 28151948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pre-hospital electrocardiograms on time to treatment and one year outcome in a rural regional ST-segment elevation myocardial infarction network.
    Kahlon TS; Barn K; Akram MM; Blankenship JC; Bower-Stout C; Carey DJ; Sun H; Tompkins Weber K; Skelding KA; Scott TD; Green SM; Berger PB
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):245-251. PubMed ID: 27142567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased monocyte to high-density lipoprotein cholesterol ratio is associated with TIMI risk score in patients with ST-segment elevation myocardial infarction.
    Sercelik A; Besnili AF
    Rev Port Cardiol (Engl Ed); 2018 Mar; 37(3):217-223. PubMed ID: 29615294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.